Tech Company Financing Transactions
Hoth Therapeutics Funding Round
Private investors invested in a $3 million Series A funding round for Hoth Therapeutics. The financing round was announced on 2/23/2018.
Transaction Overview
Company Name
Announced On
2/23/2018
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes will be used to fund operations and advance Hoth's BioLexa Platform.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Rockefeller Plz. 1039
New York, NY 10020
USA
New York, NY 10020
USA
Phone
Undisclosed
Website
Email Address
Overview
Hoth Therapeutics (Nasdaq: HOTH) is a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robb Knie
Browse more venture capital transactions:
Prev: 2/23/2018: Complai venture capital transaction
Next: 2/23/2018: FanAI venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs